Figure 2.
Clinical outcome of 111 younger adult patients with CN-AML in the validation set with either high or low expression of individual circRNAs. DFS (A), OS (B), and EFS (C) of high vs low expressers of circKLHL8. DFS (D), OS (E), and EFS (F) of high vs low expressers of circSMC1A.